PROGYNY INC

Progyny Inc. (PGNY) dips 0.49% to $28.97, trading above its 200‑day SMA yet below its 2026 peak. Despite the correction, the mid‑cap fertility‑benefits leader shows strong 52‑week upside, positioning itself for future growth in employer health‑care …

Progyny’s shares dip 0.49% to $29.12 amid mixed peer moves, yet its $2.2 bn market cap, 200‑day SMA proximity, and fertility‑care focus keep investors intrigued.

Progyny’s stock gains 2.66% as investors recognize its undervalued fertility‑benefits platform, offering a modest rally with strong long‑term upside.